GYPC and neoplasm: To assess tumor cell killing, the GPC-1high DU-145, GPC-1moderate PC3 cells or GPC-1negative Raji cells were cultured at a ratio of 10:1 with unstimulated enriched peripheral blood T cells, together with varying concentrations of MIL-38-CD3 BiTE or non-targeted control BiTE CD3-PEG, for 48 h.